GO:0110002 regulation of tRNA methylation: Epitranscriptomic Control, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0110002 regulation of tRNA methylation describes any process that modulates the frequency, rate or extent of tRNA methylation, a key epitranscriptomic modification.
• The METTL1-WDR4 complex installs m7G at tRNA position 46, and its dysregulation drives oncogenic transformation and aging.
• TRMT6/61A deposits m1A at tRNA position 58, and this modification on tRNA-derived fragments regulates gene silencing and the unfolded protein response.
• tRNA methylation is dynamically regulated by writers, erasers, and environmental cues such as oxidative stress, which can desulfurate tRNA modifications.
• Altered tRNA methylation is implicated in liver cancer, bladder cancer, and cellular senescence, making it a promising therapeutic target.
• CRISPR knockout, point-mutation, knock-in, and overexpression models are essential to dissect causal roles of tRNA methyltransferases in disease.
Description
GO:0110002 regulation of tRNA methylation is a biological process that encompasses any mechanism controlling the addition of methyl groups to tRNA molecules. tRNA methylation is a conserved epitranscriptomic modification that influences tRNA stability, decoding fidelity, and translational efficiency. The regulation of this process is critical because precise methylation patterns are required for normal cellular physiology, and their perturbation is linked to cancer, aging, and metabolic disorders. Researchers study this term to understand how cells dynamically adjust tRNA modification landscapes in response to developmental and environmental signals. The METTL1-WDR4 complex and TRMT6/61A are central writers whose activities are regulated at multiple levels, including expression, complex assembly, and substrate availability. This article synthesizes authoritative QuickGO data and verified PubMed literature to provide a research-grade overview of GO:0110002, its molecular players, disease relevance, and experimental strategies.
regulation of tRNA methylation At A Glance
| GO ID | GO:0110002 |
|---|---|
| GO term | regulation of tRNA methylation |
| Ontology | biological_process |
| Synonym | none |
| Major function | Modulates the frequency, rate or extent of tRNA methylation, impacting tRNA stability, translation, and cellular signaling |
| Key enzymes | METTL1-WDR4 (m7G), TRMT6/61A (m1A), and other tRNA methyltransferases |
| Associated diseases | Cancer (liver, bladder), aging, and metabolic disorders |
| Research methods | CRISPR knockout, point mutation, knock-in, overexpression, Ribo-seq, RNA-seq, and mass spectrometry |
What Is GO:0110002?
According to the Gene Ontology, GO:0110002 regulation of tRNA methylation is defined as any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving tRNA methylation. In other words, it covers all regulatory inputs that control when, where, and how much methyl groups are added to tRNA nucleotides, including the activity of methyltransferases, their cofactors, and upstream signaling pathways.
Why Is regulation of tRNA methylation Important in Cell Biology?
Regulation of tRNA methylation is fundamentally important because tRNA modifications directly affect protein synthesis and cellular stress responses. Dysregulation of this process can lead to mistranslation, activation of oncogenic pathways, and senescence. For researchers, understanding GO:0110002 provides mechanistic insights into how epitranscriptomic changes contribute to disease and identifies potential targets for therapeutic intervention.
• Controls translational fidelity and efficiency by modulating tRNA structure and codon-anticodon interactions.
• Regulates stem cell self-renewal and differentiation through METTL1-mediated m7G modification.
• Drives liver tumorigenesis by affecting cholesterol metabolism via m1A methylation.
• Modulates gene silencing and the unfolded protein response in bladder cancer through TRMT6/61A-dependent m1A on tRNA-derived fragments.
• Its perturbation induces cellular senescence and aging phenotypes.
• Responds to oxidative stress via desulfuration of tRNA modifications, linking metabolism to translation.
• Serves as a biomarker for cancer diagnosis and prognosis.
• Offers targets for small-molecule inhibitors or activators of tRNA methyltransferases.
• Impacts immune cell function and inflammation through tRNA modification changes.
• Provides a paradigm for studying dynamic epitranscriptomic regulation beyond DNA and histone methylation.
What Happens During regulation of tRNA methylation?
Writer Complex Assembly and Substrate Recognition
In simple terms: The cell builds a molecular machine that adds methyl groups to tRNA.
The regulation of tRNA methylation begins with the assembly of writer complexes, such as METTL1-WDR4, which recognizes specific tRNA substrates. METTL1 is the catalytic subunit, while WDR4 stabilizes the complex and aids in tRNA binding. Structural studies reveal that METTL1-WDR4 forms a heterotetramer that engages the tRNA elbow region to methylate guanosine at position 46 (m7G). Similarly, TRMT6/61A forms a complex that methylates adenosine at position 58 (m1A) in tRNA. The availability and assembly of these complexes are regulated by cellular signals and metabolic status.
Methyl Group Transfer and tRNA Modification
In simple terms: The machine attaches a small chemical tag to tRNA.
Once assembled, the writer complex catalyzes the transfer of a methyl group from S-adenosylmethionine (SAM) to the target nucleotide in tRNA. For m7G, METTL1 methylates the N7 position of guanosine, which introduces a positive charge that affects tRNA folding and interactions. For m1A, TRMT6/61A methylates the N1 position of adenosine, influencing tRNA stability and decoding. These modifications are reversible and can be removed by eraser enzymes, although the erasers for tRNA methylation are less characterized.
Regulation by Environmental and Metabolic Cues
In simple terms: The cell adjusts tRNA methylation based on stress and nutrients.
tRNA methylation is dynamically regulated in response to environmental changes such as oxidative stress, nutrient availability, and hypoxia. For example, oxidative desulfuration of tRNA modifications can alter translation during stress. Metabolic pathways, including cholesterol metabolism, can feed back to regulate tRNA methyltransferase expression. This dynamic regulation ensures that protein synthesis adapts to cellular needs.
Functional Consequences for Translation and Signaling
In simple terms: The tags on tRNA affect how proteins are made and how cells behave.
Methylation changes influence tRNA stability, codon-anticodon pairing, and ribosome recruitment, thereby affecting translation of specific mRNAs. m7G modification of Arg-TCT tRNA promotes translation of oncogenic transcripts. m1A methylation on tRNA-derived fragments regulates gene silencing and the unfolded protein response. These functional outcomes link tRNA methylation regulation to cell proliferation, differentiation, and survival.
Key Genes Involved in GO:0110002 regulation of tRNA methylation
The following genes and proteins are central to the regulation of tRNA methylation, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| METTL1 | Catalytic subunit of m7G tRNA methyltransferase complex | Oncogenic transformation, stem cell self-renewal, aging |
| WDR4 | Essential partner of METTL1 for complex stability and tRNA binding | Mutations cause microcephalic primordial dwarfism; cancer |
| TRMT6 | Subunit of m1A tRNA methyltransferase complex | Bladder cancer, gene silencing, unfolded protein response |
| TRMT61A | Catalytic subunit of m1A tRNA methyltransferase complex | Liver tumorigenesis, cholesterol metabolism |
| TRMT61B | Mitochondrial tRNA methyltransferase for m1A | Mitochondrial function and disease |
| TRMT10A | m1G tRNA methyltransferase | Neurodevelopmental disorders, diabetes |
| TRMT10C | Mitochondrial tRNA methyltransferase | Mitochondrial disease |
| TRMT1 | m2,2G tRNA methyltransferase | Intellectual disability, redox homeostasis |
| TRMT2A | m5U tRNA methyltransferase | Cancer, cell cycle regulation |
| TRMT2B | Mitochondrial m5U tRNA methyltransferase | Mitochondrial translation |
| TRMT5 | m1G tRNA methyltransferase | Mitochondrial dysfunction, disease |
| TRMT9B | tRNA methyltransferase for wybutosine derivatives | Cancer, translation fidelity |
| TRMT11 | m2G tRNA methyltransferase | Ribosome biogenesis, stress response |
| TRMT12 | tRNA methyltransferase for wybutosine | Translation regulation |
| TRMT13 | tRNA methyltransferase for m1G | Unknown disease links |
| TRMT44 | tRNA methyltransferase for m5C | Cancer, RNA stability |
| FTSJ1 | 2'-O-methylation of tRNA | Intellectual disability, translation |
| NSUN2 | m5C tRNA methyltransferase | Cancer, stem cell differentiation |
How Is regulation of tRNA methylation Regulated?
The regulation of tRNA methylation is controlled by multiple layers of cellular signaling. The mTOR pathway, a master regulator of cell growth, can influence the expression of tRNA methyltransferases and the availability of SAM. The integrated stress response (ISR) can modulate tRNA modification patterns to favor translation of stress-responsive mRNAs. Oxidative stress induces desulfuration of tRNA modifications, which alters translation. Additionally, metabolic pathways such as cholesterol biosynthesis can feedback on tRNA methylation. These regulatory mechanisms ensure that tRNA methylation is dynamically tuned to cellular demands.
regulation of tRNA methylation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| METTL1 | Liver cancer, aging, stem cell self-renewal | Knockout and overexpression in hepatoma cell lines |
| TRMT61A | Liver tumorigenesis, cholesterol metabolism | Liver-specific knockout mice |
| TRMT6/61A | Bladder cancer, unfolded protein response | Knockdown and overexpression in bladder cancer cells |
| WDR4 | Microcephalic primordial dwarfism, cancer | Patient-derived mutations knock-in |
| NSUN2 | Cancer, intellectual disability | Knockout in neuronal and cancer cell lines |
Cancer
Dysregulation of tRNA methylation is increasingly recognized as a driver of cancer. METTL1-mediated m7G modification of Arg-TCT tRNA promotes oncogenic transformation by enhancing translation of growth-promoting transcripts. In liver cancer, TRMT61A-dependent m1A methylation drives tumorigenesis by regulating cholesterol metabolism. TRMT6/61A-dependent m1A on tRNA-derived fragments regulates gene silencing and the unfolded protein response in bladder cancer. These findings highlight tRNA methylation as a promising therapeutic target.
Aging and Senescence
Perturbation of METTL1-mediated m7G modification induces cellular senescence and aging phenotypes. This links tRNA methylation to the aging process and suggests that maintaining proper tRNA modification is important for longevity.
Metabolic Disorders
tRNA methylation regulates cholesterol metabolism, and its dysregulation can contribute to metabolic disorders such as hypercholesterolemia. The interplay between tRNA modifications and metabolism is an emerging area of research.
From regulation of tRNA methylation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does METTL1 loss affect tRNA m7G levels and translation? | METTL1 knockout cell lines |
| Does a specific point mutation in WDR4 disrupt complex assembly? | WDR4 point-mutation knock-in |
| Can overexpression of TRMT61A drive liver tumorigenesis? | TRMT61A overexpression in hepatocytes |
| What is the role of TRMT6/61A in bladder cancer? | TRMT6/61A knockdown and knockout in bladder cancer cells |
| Does METTL1-mediated m7G regulate senescence? | METTL1 knockout and rescue in fibroblasts |
| How does oxidative stress alter tRNA methylation? | Oxidative stress treatment in cell lines with tagged methyltransferases |
How to Study the regulation of tRNA methylation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Ribo-seq | Translation efficiency and ribosome occupancy | Assessing impact of tRNA methylation on protein synthesis |
| LC-MS/MS | Levels of specific tRNA modifications | Quantifying m7G and m1A after genetic manipulation |
| RNA-seq | tRNA expression and modification-sensitive sequencing | Transcriptome-wide effects of tRNA methylation |
| Proteomics | Protein interactions and complex composition | Identifying METTL1-WDR4 partners |
| CRISPR screening | Gene essentiality and modifiers of tRNA methylation | Discovering regulators of tRNA methylation |
| Fluorescence microscopy | Subcellular localization of tRNA and enzymes | Visualizing tRNA methylation dynamics |
| Northern blot | tRNA stability and processing | Validating tRNA degradation upon methylation loss |
| Polysome profiling | mRNA translation status | Linking tRNA methylation to specific mRNA translation |
Ribo-seq and RNA-seq
Ribosome profiling (Ribo-seq) measures translation efficiency and can reveal how tRNA methylation changes affect codon-specific translation. RNA-seq can quantify tRNA abundance and modification levels when combined with specific treatments.
Mass Spectrometry and Modification Mapping
Liquid chromatography-tandem mass spectrometry (LC-MS/MS) allows direct quantification of tRNA modifications such as m7G and m1A. This method is essential for validating the effects of genetic perturbations on tRNA methylation.
Proteomics and Interactomics
Affinity purification coupled with mass spectrometry can identify protein complexes associated with tRNA methyltransferases, such as METTL1-WDR4. This helps uncover regulatory subunits and signaling partners.
Imaging and Reporter Assays
Fluorescent tRNA reporters and single-molecule imaging can visualize tRNA localization and modification dynamics in live cells. These techniques complement biochemical approaches.
How CRISPR Can Be Used to Study GO:0110002 regulation of tRNA methylation
Knockout
CRISPR knockout of METTL1 or TRMT6/61A abolishes specific tRNA methylation marks, enabling researchers to study loss-of-function phenotypes such as reduced translation of oncogenic transcripts or induction of senescence. Knockout cell lines are essential for validating the causal role of these enzymes in disease models.
Point Mutation
Point mutations in catalytic residues of METTL1 or WDR4 can dissect the enzymatic activity from scaffolding functions. For example, mutations that disrupt SAM binding or tRNA recognition help clarify the contribution of methylation to complex phenotypes.
Knock-in
Knock-in of disease-associated mutations, such as those in WDR4 linked to microcephalic primordial dwarfism, allows modeling of human genetic disorders in cell lines or mice. Tagged knock-in of METTL1 with fluorescent or affinity tags facilitates localization and interactome studies.
Overexpression
Overexpression of METTL1 or TRMT61A can drive oncogenic transformation and tumorigenesis in cell culture and animal models. Overexpression models are useful for studying gain-of-function effects and for screening inhibitors of tRNA methylation.
How EDITGENE Supports regulation of tRNA methylation Research
Researchers studying regulation of tRNA methylation-related genes often need to determine whether a candidate gene is causally involved in tRNA modification, translation, and disease phenotypes. EDITGENE provides comprehensive CRISPR-based services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for regulation of tRNA methylation research.
Frequently Asked Questions About regulation of tRNA methylation
What is GO:0110002 regulation of tRNA methylation?
GO:0110002 is a Gene Ontology biological process term defined as any process that modulates the frequency, rate or extent of tRNA methylation, a key epitranscriptomic modification.
What genes are involved in regulation of tRNA methylation?
Key genes include METTL1, WDR4, TRMT6, TRMT61A, TRMT61B, TRMT10A, TRMT10C, TRMT1, TRMT2A, TRMT2B, TRMT5, TRMT9B, TRMT11, TRMT12, TRMT13, TRMT44, FTSJ1, and NSUN2.
How does METTL1 regulate tRNA methylation?
METTL1 forms a complex with WDR4 to catalyze m7G methylation at position 46 of tRNA, which affects tRNA stability and translation of specific mRNAs.
What diseases are linked to tRNA methylation dysregulation?
Dysregulation is linked to cancers such as liver and bladder cancer, as well as aging and metabolic disorders.
What is the role of TRMT6/61A in tRNA methylation?
TRMT6/61A deposits m1A at position 58 of tRNA, and this modification on tRNA-derived fragments regulates gene silencing and the unfolded protein response.
How can CRISPR be used to study regulation of tRNA methylation?
CRISPR knockout, point mutation, knock-in, and overexpression models allow researchers to dissect the causal roles of tRNA methyltransferases in cellular and disease phenotypes.
What methods are used to measure tRNA methylation?
LC-MS/MS, Ribo-seq, RNA-seq, and proteomics are commonly used to quantify tRNA modifications and their functional consequences.
Is tRNA methylation reversible?
Yes, tRNA methylation is dynamic and can be reversed by eraser enzymes, although the erasers for tRNA modifications are less characterized than those for DNA and histones.
What is the connection between tRNA methylation and aging?
Perturbation of METTL1-mediated m7G modification induces cellular senescence and aging phenotypes, suggesting a role in longevity.
How does oxidative stress affect tRNA methylation?
Oxidative stress can induce desulfuration of tRNA modifications, which alters translation and cellular stress responses.
Conclusion
GO:0110002 regulation of tRNA methylation is a critical epitranscriptomic process that controls translation and cellular physiology. Its dysregulation is implicated in cancer, aging, and metabolic disorders, making it a vibrant area of research. Understanding the molecular players and regulatory mechanisms provides opportunities for therapeutic intervention. EDITGENE offers a full suite of CRISPR services to help researchers uncover the roles of tRNA methylation in health and disease.
References
- 1. Ruiz-Arroyo VM et al.. 2023. Structures and mechanisms of tRNA methylation by METTL1-WDR4.. Nature 613(7943):383-390 PMID: 36599982
- 2. Orellana EA et al.. 2021. METTL1-mediated m(7)G modification of Arg-TCT tRNA drives oncogenic transformation.. Mol Cell 81(16):3323-3338.e14 PMID: 34352207
- 3. Wang Y et al.. 2021. N(1)-methyladenosine methylation in tRNA drives liver tumourigenesis by regulating cholesterol metabolism.. Nat Commun 12(1):6314 PMID: 34728628
- 4. Wang S et al.. 2026. tRNA methylation: functional insights and epitranscriptomic regulation.. Cell Commun Signal 24(1) PMID: 42351149
- 5. Su Z et al.. 2022. TRMT6/61A-dependent base methylation of tRNA-derived fragments regulates gene-silencing activity and the unfolded protein response in bladder cancer.. Nat Commun 13(1):2165 PMID: 35444240
- 6. Fu Y et al.. 2024. Perturbation of METTL1-mediated tRNA N(7)- methylguanosine modification induces senescence and aging.. Nat Commun 15(1):5713 PMID: 38977661
- 7. Mo Y et al.. 2026. Translational regulation by oxidative desulfuration of tRNA modifications.. Nat Commun 17(1) PMID: 41807381
- 8. Lyko F. 2018. The DNA methyltransferase family: a versatile toolkit for epigenetic regulation.. Nat Rev Genet 19(2):81-92 PMID: 29033456
